Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.91)
# 676
Out of 4,711 analysts
77
Total ratings
39.47%
Success rate
14.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UPB Upstream Bio | Initiates: Overweight | $75 | $16.21 | +362.68% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $0.93 | +654.07% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $5.61 | +363.46% | 2 | Oct 30, 2024 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $48 → $51 | $30.78 | +65.69% | 3 | Oct 11, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $25.50 | +45.10% | 2 | Sep 23, 2024 | |
| ZURA Zura Bio | Maintains: Overweight | $26 | $2.28 | +1,040.35% | 2 | Sep 19, 2024 | |
| SLRN Acelyrin | Maintains: Overweight | $68 → $20 | $3.15 | +534.92% | 2 | Aug 14, 2024 | |
| IMUX Immunic | Reiterates: Overweight | $28 | $1.00 | +2,700.00% | 3 | Jul 16, 2024 | |
| CRNX Crinetics Pharmaceuticals | Maintains: Overweight | $97 | $53.60 | +80.97% | 4 | Jul 2, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $270 | $76.52 | +252.85% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $47.44 | +60.20% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $8.25 | +203.03% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $11.41 | +162.93% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $6.25 | +92.00% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $42.02 | -14.33% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.68 | +1,215.79% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $43.67 | +312.18% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.84 | +1,685.71% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $308.44 | +8.94% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.23 | +395.36% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $14.55 | +449.83% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $45.18 | +105.84% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $27.90 | +233.33% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $20.65 | +214.77% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $25.86 | +120.42% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $4.95 | +1,253.54% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $41.49 | -15.64% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $1.20 | +1,733.33% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $6.28 | +1,285.35% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $94 | $15.22 | +517.61% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $39.84 | +339.26% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $0.71 | +1,299.19% | 1 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $48.87 | +47.33% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $13.21 | +104.39% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $7.94 | +139.29% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.24 | +2,132.14% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.67 | +2,295.21% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.62 | +2,805.10% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $0.46 | +4,465.22% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $15.48 | +397.42% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $41.51 | +85.50% | 1 | Jul 31, 2020 |
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $16.21
Upside: +362.68%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $0.93
Upside: +654.07%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $5.61
Upside: +363.46%
Edgewise Therapeutics
Oct 11, 2024
Maintains: Overweight
Price Target: $48 → $51
Current: $30.78
Upside: +65.69%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $25.50
Upside: +45.10%
Zura Bio
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $2.28
Upside: +1,040.35%
Acelyrin
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $3.15
Upside: +534.92%
Immunic
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.00
Upside: +2,700.00%
Crinetics Pharmaceuticals
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $53.60
Upside: +80.97%
Praxis Precision Medicines
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $76.52
Upside: +252.85%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $47.44
Upside: +60.20%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $8.25
Upside: +203.03%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $11.41
Upside: +162.93%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $6.25
Upside: +92.00%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $42.02
Upside: -14.33%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.68
Upside: +1,215.79%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $43.67
Upside: +312.18%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.84
Upside: +1,685.71%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $308.44
Upside: +8.94%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.23
Upside: +395.36%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $14.55
Upside: +449.83%
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $45.18
Upside: +105.84%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $27.90
Upside: +233.33%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $20.65
Upside: +214.77%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $25.86
Upside: +120.42%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $4.95
Upside: +1,253.54%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $41.49
Upside: -15.64%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $1.20
Upside: +1,733.33%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $6.28
Upside: +1,285.35%
Jan 27, 2023
Initiates: Overweight
Price Target: $94
Current: $15.22
Upside: +517.61%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $39.84
Upside: +339.26%
Aug 12, 2022
Initiates: Overweight
Price Target: $10
Current: $0.71
Upside: +1,299.19%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $48.87
Upside: +47.33%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $13.21
Upside: +104.39%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $7.94
Upside: +139.29%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.24
Upside: +2,132.14%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.67
Upside: +2,295.21%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.62
Upside: +2,805.10%
Aug 26, 2020
Initiates: Overweight
Price Target: $21
Current: $0.46
Upside: +4,465.22%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $15.48
Upside: +397.42%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $41.51
Upside: +85.50%